Quantcast
Home > Quotes > BSX

Boston Scientific Corporation Common Stock (BSX) Quote & Summary Data

BSX 
$37.21
*  
0.74
2.03%
Get BSX Alerts
*Delayed - data as of Nov. 16, 2018  -  Find a broker to begin trading BSX now
Exchange:NYSE
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

1 Year Target
42
Today's High / Low
$ 37.73 / $ 36.34
Share Volume
7,481,841
90 Day Avg. Daily Volume
6,990,413
Previous Close
$ 36.47
52 Week High / Low
$ 39.44 / $ 24.54
Market Cap
51,491,227,061
P/E Ratio
79.17
Forward P/E (1y)
26.24
Earnings Per Share (EPS)
$ 0.47
Annualized Dividend
N/A
Ex Dividend Date
N/A
Dividend Payment Date
N/A
Current Yield
0 %
Beta
1.04

Intraday Chart

Shares Traded

Share Volume:
7,481,841
90 Day Avg. Daily Volume:
6,990,413

P/E Ratio

P/E Ratio:
79.17
Forward P/E (1y):
26.24
Earnings Per Share (EPS):
$ 0.47

Trading Range

The current last sale of $37.21 is 51.63% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 37.73 $ 39.44
 Low: $ 36.34 $ 24.54

ETFs with BSX as a Top 10 Holding*

Weighting ETF Name (Symbol) 100-Day Price Change (%)
5.16% iShares U.S. Medical Devices ETF (IHI) +6.29 (3.11%)
*Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change.
**Green highlights the top performing ETF by % change in the past 100 days.

Company Description (as filed with the SEC)

Boston Scientific Corporation is a global developer, manufacturer and marketer of medical devices that are used in a broad range of interventional medical specialties. Our mission is to transform lives through innovative medical solutions that improve the health of patients around the world. As a medical technology leader for more than 35 years, we advance science for life by providing a broad range of high performance solutions to address unmet patient needs and reduce the cost of healthcare. When used in this report, the terms "we," "us," "our" and "the Company" mean Boston Scientific Corporation and its divisions and subsidiaries. Our history began in the late 1960s when our co-founder, John Abele, acquired an equity interest in Medi-tech, Inc., a research and development company focused on developing alternatives to surgery. In 1969, Medi-tech introduced a family of steerable catheters used in some of the world's first less-invasive procedures.  ... More ...  


Risk Grade

Where does BSX fit in the risk graph?


Risk Grade Scale

Consensus Recommendation

Analyst Info



Another Bailout?? Why is the SEC boosting big banks and HFT's bottom lines?
x